Ocugen (OCGN) Change in Account Payables (2014 - 2019)
Ocugen (OCGN) reported Change in Account Payables of -$560000.0 for Q2 2019, down 166.27% on a YoY basis from $845000.0 in Q2 2018, and down 14.05% quarter-over-quarter from -$491000.0 in Q1 2019.
Ocugen (OCGN) Change in Account Payables (2014 - 2019) Analysis & Trends
Ocugen has reported Change in Account Payables for 6 years, with the latest figure at -$560000.0 in Q2 2019.
- For the quarter ending Q2 2019, Change in Account Payables fell 166.27% year-over-year to -$560000.0; the trailing twelve-month figure through Jun 2019 stood at -$1.8 million (down 225.3% YoY), and the FY2018 full-year result was $689000.0, up 291.39% from the prior year.
- Change in Account Payables for Q2 2019 stood at -$560000.0, down from -$491000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $845000.0 in Q2 2018, with the low at -$3.1 million in Q4 2015.
- Historically, Change in Account Payables has averaged -$202058.8 across 5 years, with a median of -$172000.0 in 2018.
- The largest YoY upside for Change in Account Payables was 564.71% in 2015 against a maximum downside of 9484.85% in 2015.
- Ocugen's Change in Account Payables stood at -$3.1 million in 2015, then jumped by 115.79% to $489000.0 in 2016, then decreased by 18.0% to $401000.0 in 2017, then plunged by 142.89% to -$172000.0 in 2018, then sank by 225.58% to -$560000.0 in 2019.
- The last three Change in Account Payables figures came in at -$560000.0 (Q2 2019), -$491000.0 (Q1 2019), and -$172000.0 (Q4 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -560,000.00 |
| Jun 30, 2019 | -560,000.00 |
| Mar 31, 2019 | -491,000.00 |
| Mar 31, 2019 | -491,000.00 |
| Dec 31, 2018 | -172,000.00 |
| Dec 31, 2018 | -172,000.00 |
| Sep 30, 2018 | -570,000.00 |
| Sep 30, 2018 | -570,000.00 |
| Jun 30, 2018 | 845,000.00 |
| Jun 30, 2018 | 845,000.00 |
| Mar 31, 2018 | 586,000.00 |
| Mar 31, 2018 | 586,000.00 |
| Dec 31, 2017 | 401,000.00 |
| Dec 31, 2017 | 401,000.00 |
| Sep 30, 2017 | -401,000.00 |
| Sep 30, 2017 | -401,000.00 |
| Mar 31, 2017 | -360,000.00 |
| Mar 31, 2017 | -360,000.00 |
| Dec 31, 2016 | 489,000.00 |
| Dec 31, 2016 | 489,000.00 |